Jacobs Levy Equity Management’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-33,530
| Closed | -$165K | – | 1142 |
|
|
2021
Q3 | $165K | Sell |
33,530
-17,173
| -34% | -$84.5K | ﹤0.01% | 999 |
|
|
2021
Q2 | $268K | Sell |
50,703
-249,543
| -83% | -$1.32M | ﹤0.01% | 943 |
|
|
2021
Q1 | $1.44M | Buy |
300,246
+78,456
| +35% | +$377K | 0.01% | 657 |
|
|
2020
Q4 | $960K | Buy |
221,790
+45,800
| +26% | +$198K | 0.01% | 733 |
|
|
2020
Q3 | $725K | Buy |
175,990
+49,287
| +39% | +$203K | 0.01% | 720 |
|
|
2020
Q2 | $324K | Sell |
126,703
-37,653
| -23% | -$96.3K | ﹤0.01% | 871 |
|
|
2020
Q1 | $475K | Buy |
164,356
+14,377
| +10% | +$41.6K | 0.01% | 764 |
|
|
2019
Q4 | $568K | Buy |
149,979
+71,379
| +91% | +$270K | 0.01% | 770 |
|
|
2019
Q3 | $402K | Buy |
+78,600
| New | +$402K | ﹤0.01% | 748 |
|
|
2015
Q2 | – | Sell |
-19,300
| Closed | -$338K | – | 880 |
|
|
2015
Q1 | $338K | Buy |
+19,300
| New | +$338K | 0.01% | 632 |
|